iWisdom Expands with a New Office in Riyadh, Saudi Arabia
We are proud to announce the opening of an office in the capital city of Saudi Arabia, Riyadh. This is iWisdom’s second new office to open this year following the opening of the Boston office to support the biotech hub on the east coast of the US.
We work in partnership with biopharma companies, by helping them to take a lead in the biotech development and commercialization space in Saudi Arabia with of focus on speed to outcomes, through ensuring rapid value creation by realizing the upside of uncertainty, and the smart diversification of risk in the biopharmaceutical space.
We leverages our partners 120 years combined experience and extensive partner network to provide Saudi Arabian companies with a gateway to the global play and activating global biopharma players appetite for The Kingdom.
iWisdom’s Saudi specific experience includes products with sales of $0.3bn plus sales in 10 Middle East countries. Our centre of excellence experience and track record in vaccines is second to none.
We have a well-established impact model, consisting of three parts; commercialise, advise and invest, ensures speed to outcomes and finding the upsides. The synergies that we leverage by executing the modular model is an offering that is unique to iWisdom in Saudi Arabia.
We recognize that the commercialization pathway is rarely straightforward. Therefore, we offer support at any stage of the process, with a track record of over 80 projects. With a focus on developing activation blueprints and execution capabilities, we will facilitate the Saudization strategy including technology transfers.
Comments